Dr. Li Feng's lab focuses on developing advanced MRI techniques to improve the diagnosis and management of chronic liver diseases, particularly metabolic-associated steatotic liver disease (MASLD). They are pioneering a new method that provides non-invasive imaging biomarkers to assess liver inflammation and fibrosis. This research aims to offer alternative solutions to invasive procedures like liver biopsies.

Dr. Marcin Imielinski's lab at NYU School of Medicine researches how the original cell type from which lung cancer arises affects the disease's behavior and treatment. They focus on understanding the genetic changes that accompany lung adenocarcinoma, a common and deadly form of lung cancer. By analyzing mutations in lung cancer samples, the lab aims to identify the cell of origin for these tumors and improve diagnostic and therapeutic strategies.

Dr. Kamal Mohan Khanna's lab focuses on the role of different macrophage populations in the lung and their functions during immune responses. The research explores how factors like obesity and diabetes can alter these immune responses, especially in the context of respiratory viral infections like COVID-19 and influenza. By understanding how these macrophages operate and adapt, the lab aims to develop new therapeutic strategies for improving immune function in affected individuals.

Dr. Guillaume Madelin's lab at NYU School of Medicine focuses on using advanced MRI techniques to better understand and treat joint and breast conditions. Their research aims to develop new imaging methods that can monitor joint health after injuries, such as ACL tears, and assess tumor response during breast cancer treatments. By combining different MRI modalities, they hope to predict outcomes and optimize therapies for patients.

Dr. Riccardo Lattanzi's research lab focuses on enhancing Magnetic Resonance Imaging (MRI) technology through innovative software and design techniques. The lab works on optimizing radiofrequency coils essential for MRI, aiming to improve imaging quality and efficiency. They also develop open-source platforms like Cloud MR to make MRI research more accessible and educational for users around the world.

Dr. Cristina Alberini's lab focuses on understanding how memories are formed and maintained at the molecular level. They study the role of certain genes, particularly insulin-like growth factor 2 (IGF-2), in strengthening long-term memories. By exploring the mechanisms of memory consolidation, the lab aims to develop strategies to treat cognitive impairments associated with disorders like autism and Alzheimer's disease.

Dr. Eric Klann's lab at New York University focuses on understanding how protein synthesis affects memory and language in brain disorders. By studying specific brain regions in mice, they aim to uncover the processes behind memory storage, retrieval, and loss. They are also investigating how abnormalities in protein translation contribute to diseases like Alzheimer's and fragile X syndrome, with hopes of finding new treatment targets.

Dr. Anli A Liu's research lab at NYU School of Medicine focuses on understanding how the brain organizes and recalls memories, particularly through the interactions between the hippocampus and the neocortex. By studying brain activity in epilepsy patients while they watch films and engage in visual exploration, the lab aims to uncover how memories are formed and segmented into distinct events. This research has important implications for improving diagnosis and treatment of memory disorders.

Dr. Eva Hernando's lab at NYU School of Medicine focuses on understanding the mechanisms behind cancer metastasis, particularly in melanoma and brain tumors. The lab investigates how certain proteins and epigenetic changes affect tumor spread and explores new therapeutic strategies to inhibit brain metastasis. Ultimately, the research aims to improve treatment options for patients with limited prospects.

Dr. Liat Shenhav's lab at NYU School of Medicine investigates how early-life factors, particularly breastfeeding and the development of the microbiome, affect respiratory health in children. They are using advanced algorithms and animal studies to uncover the connections between microbial colonization and the risk of childhood asthma. By analyzing data from large birth cohorts, the lab aims to improve our understanding of how microbial communities influence health outcomes and identify new prevention strategies for respiratory diseases.

Dr. Jin Kim Montclare's lab at New York University focuses on developing innovative methods for delivering therapeutic RNA molecules to treat conditions like diabetic wounds. By creating hybrid materials composed of proteins and lipids, the lab aims to enhance the effectiveness of gene delivery systems. Their research strives to overcome significant challenges in achieving safe and efficient cellular uptake of treatments, with a long-term goal of addressing a variety of skin disorders.

Un Jung Kang's research lab focuses on understanding multiple system atrophy (MSA), a rare and fatal neurodegenerative disease. The lab uses advanced single nucleus RNA sequencing techniques to investigate how different brain cells are affected by MSA. By analyzing gene expression changes in postmortem brain tissue from MSA patients, the lab aims to uncover mechanisms leading to neuronal death and explore potential therapeutic targets.

Dr. Konstantin Ichtchenko's lab focuses on developing new treatments for botulinum neurotoxin poisoning, a serious condition that can cause paralysis and respiratory failure. The team aims to create innovative therapeutics that can specifically target and neutralize the neurotoxin's harmful effects within nerve cells. Their work is not only relevant for addressing botulism but also has implications for treating other neurodegenerative diseases.

Alisha Jones's lab at New York University focuses on understanding how long noncoding RNAs (lncRNAs) change their shape and how these changes affect their biological functions. The team studies the processes of lncRNA splicing and aims to uncover the molecular mechanisms by which these RNA molecules regulate important biological processes, including gene silencing. By integrating research with a hands-on training program for students of all levels, the lab prepares future scientists to explore the therapeutic potential of lncRNAs in disease.

Dmitry Rinberg's lab at NYU focuses on understanding how the brain processes smells and how this ability can be harnessed for medical diagnostics. They investigate the neural mechanisms involved in odor perception and how specific smells can indicate various health conditions. Using advanced imaging techniques, the lab aims to explore the connections between nerve cells in the olfactory system and how these contribute to disease detection. By doing so, they hope to uncover fundamental principles of olfaction while also paving the way for innovative diagnostic tools.

Dr. Christopher Y Park's lab focuses on improving diagnosis and treatment for patients with follicular lymphoma, a type of cancer affecting B-cells. The lab combines advanced genomic studies and innovative mouse models to understand how changes in the tumor microenvironment influence disease progression and response to therapy. By identifying reliable biomarkers, they aim to enhance patient stratification and treatment outcomes for those at high risk of early disease progression.

Dr. Giuseppina Pilloni's research lab at NYU focuses on innovating noninvasive brain stimulation techniques, specifically transcranial direct current stimulation (tDCS), to improve treatment for neuropsychiatric symptoms like depression. The lab aims to integrate heart rate variability (HRV) as a biomarker to tailor tDCS therapies, making them more personalized and effective. By utilizing telehealth technologies, they seek to enhance accessibility and scalability of mental health interventions.

Dr. Sumit Chopra's research lab is focused on using artificial intelligence to improve the detection of prostate cancer through innovative MRI technology. The lab aims to make MRI diagnostics more accessible and effective, specifically for early detection of clinically significant prostate cancer (CSPCA). By leveraging machine learning to analyze reduced data from MRI scans, the team plans to enable point-of-care diagnostics that could revolutionize how prostate cancer is identified and monitored.

Dr. Sunil V Rao's lab focuses on improving treatments for patients with submassive pulmonary embolism (PE) using advanced techniques like catheter-directed therapy (CDT). The research aims to assess the effectiveness and safety of CDT compared to traditional anticoagulant therapy. By investigating the long-term impacts of these treatments on patients' health and quality of life, the lab strives to change clinical practices and enhance patient outcomes.

Dr. Giulietta Maria Riboldi's lab at NYU is focused on understanding Early Onset Parkinson's Disease (EOPD), which occurs before the age of 50. The lab studies how genetic factors, inflammatory responses, and alpha-synuclein protein accumulation contribute to different subtypes of EOPD. By analyzing patient data and biological samples, the lab works to identify distinct disease mechanisms that could lead to better-tailored treatments and improved patient care.